Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years, including up to 10% indirect costs)
Summary: Funds transformative, interdisciplinary research advancing the understanding and treatment of neurodegenerative diseases, empowering early-to-mid-career investigators.
Key Information: Forecasted cycle—dates are projected; check program page for updates.